SEC Company Response from Greenwich LifeSciences, Inc. (GLSI) (CIK 0001799788) (GLSI) — Dec 15, 2020
Greenwich LifeSciences, Inc. (GLSI) (CIK 0001799788)
Date: Dec. 15, 2020 · CIK: 0001799788 · Accession: 0001493152-20-023667
AI Filing Summary & Sentiment
Show Raw Text
CORRESP
1
filename1.htm
December
15, 2020
VIA
EDGAR
Securities
and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
DC 20549
RE:
Greenwich
LifeSciences, Inc. (CIK: 0001799788)
Registration
Statement on Form S-1 (the “Registration Statement”)
Ladies
and Gentlemen:
Pursuant
to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933,
as amended (the “Securities Act”), Aegis Capital Corp. hereby requests acceleration of the effective date of the above-referenced
Registration Statement so that it will become effective at 5:00 p.m. Eastern Time, December 17, 2020, or as soon thereafter as
practicable.
Pursuant
to Rule 460 under the Securities Act, please be advised that we will distribute as many electronic copies of the proposed form
of preliminary prospectus as appears to be reasonable to secure adequate distribution.
By:
AEGIS
CAPITAL CORP.
By:
/s/
Victor Halpert
Name:
Victor
Halpert
Title:
Managing
Director